Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Medpace Holdings, Inc. (MEDP) vs Revvity Inc. (RVTY)

Medpace Holdings, Inc. and Revvity Inc. are both Diagnostics & Research companies. Medpace Holdings, Inc. and Revvity Inc. are of similar size ($17.3B and $16.8B). Medpace Holdings, Inc. trades at the lower P/E: 35.6× against 72.0×. Medpace Holdings, Inc. grew revenue faster over the last twelve months: 24.7% against 4.05%. Medpace Holdings, Inc. has the higher net margin (17.7% vs 8.16%) and the lower return on invested capital (0.00% vs 2.38%). Across the 22 metrics below, Medpace Holdings, Inc. leads on 17 and Revvity Inc. on 5.

Valuation

Metric MEDP RVTY Diagnostics & Research median
P/E 35.59 71.96 33.95
P/S 6.27 5.79 4.87
P/B 40.19 2.33 3.12
Price to free cash flow 24.67 29.84 34.02
EV/EBITDA 27.97 24.55 25.20
EV/Sales 6.14 6.54 5.66
Earnings yield 2.81% 1.39% (1.75%)
Free cash flow yield 4.05% 3.35% (0.13%)

Profitability

Metric MEDP RVTY Diagnostics & Research median
Gross margin 72.35% 54.98% 50.89%
Operating margin 20.97% 12.32% (8.57%)
Net margin 17.67% 8.16% (6.37%)
Free cash flow margin 25.40% 19.58% 0.00%
Return on equity 162.15% 3.21% (2.92%)
Return on assets 27.09% 1.95% (6.71%)
Return on invested capital 0.00% 2.38% 0.00%

Growth

Metric MEDP RVTY Diagnostics & Research median
Revenue growth (TTM) 24.67% 4.05% 7.69%
EPS growth (last fiscal year) 20.98% (5.91%) —
Revenue growth, 5-year CAGR 22.27% 1.41% 7.40%
Net income growth, 5-year CAGR 25.50% (19.82%) 0.00%

Health

Metric MEDP RVTY Diagnostics & Research median
Debt to equity 0.00 0.44 0.11
Current ratio 0.73 1.80 2.02
Net debt to EBITDA (0.88) 3.00 0.78

Dividend

Metric MEDP RVTY Diagnostics & Research median
Dividend yield — 0.27% 0.70%
Payout ratio 0.00 0.05 0.00

Size

Metric MEDP RVTY Diagnostics & Research median
Market cap 17.32b 16.81b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack